AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15151958 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemoglobin responders (increase > or =2 g/dl)
Number of subjects: 5
Study 15151958 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with meaningful improvement in fatigue (FACT Fatigue change score > or =3 points)
Number of subjects: 5
Study 15151958 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients whose fatigue improved
Number of subjects: 5
Study 11590519 — intervention group
Group type: EXPERIMENTAL
Intervention: Nevirapine (NVP) or efavirenz (EFV)
Number of subjects: 5
Study 11590519 — intervention group
Group type: COMPARATOR
Intervention: Two NRTIs and one NNRTI
Number of subjects: 5
Study 9453529 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline exercise test 1
Number of subjects: 81
Study 9453529 — intervention group
Group type: EXPERIMENTAL
Intervention: Predetermined submaximal level
Number of subjects: 81
Study 8288662 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg enoxaparin every 12 hours (194 patients)
Number of subjects: 610
Study 8288662 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg enoxaparin once daily (203 patients)
Number of subjects: 610
Study 8288662 — intervention group
Group type: COMPARATOR
Intervention: 5000 units unfractionated heparin every 8 hours (207 patients)
Number of subjects: 610
Study 29366744 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) injection
Number of subjects: 54
Study 29366744 — intervention group
Group type: COMPARATOR
Intervention: Hyaluronic acid (HA) injection
Number of subjects: 54
Study 27434056 — intervention group
Group type: COMPARATOR
Intervention: 125 mg L-homoarginine once daily for 4 weeks
Number of subjects: 20
Study 27434056 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 20
Study 24685829 — intervention group
Group type: EXPERIMENTAL
Intervention: Pertuzumab, trastuzumab, and docetaxel
Number of subjects: 808
Study 24685829 — intervention group
Group type: COMPARATOR
Intervention: Placebo, trastuzumab, and docetaxel
Number of subjects: 808
Study 22892359 — intervention group
Group type: EXPERIMENTAL
Intervention: Insult/nonsexually coercive fantasy material
Number of subjects: 59
Study 22892359 — intervention group
Group type: EXPERIMENTAL
Intervention: No insult/sexually coercive fantasy material
Number of subjects: 59
Study 22892359 — intervention group
Group type: EXPERIMENTAL
Intervention: Insult/sexually coercive fantasy material
Number of subjects: 59
Study 20826244 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel (300 mg loading dose, followed by 75 mg daily) in addition to aspirin
Number of subjects: 750
Study 20826244 — intervention group
Group type: COMPARATOR
Intervention: Placebo in addition to aspirin
Number of subjects: 750
Study 18028997 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal CO2 treatment
Number of subjects: 89
Study 18028997 — intervention group
Group type: COMPARATOR
Intervention: Placebo (air) treatment
Number of subjects: 89
Study 16861083 — intervention group
Group type: EXPERIMENTAL
Intervention: 95% ethyl alcohol rinse
Number of subjects: 40
Study 16861083 — intervention group
Group type: COMPARATOR
Intervention: NaOCl rinse
Number of subjects: 40
Study 12590230 — intervention group
Group type: EXPERIMENTAL
Intervention: Witzel balloon dilatation
Number of subjects: 34
Study 12590230 — intervention group
Group type: COMPARATOR
Intervention: Botulinum toxin (80 units into the LES)
Number of subjects: 34
Study 12590230 — intervention group
Group type: COMPARATOR
Intervention: Crossover to Witzel dilatation
Number of subjects: 34
Study 10865321 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual acuity worse than 20/40 in the 65-74 age group
Number of subjects: 3821
Study 10865321 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual acuity worse than 20/40 in the 80-84 age group
Number of subjects: 3821
Study 10865321 — intervention group
Group type: EXPERIMENTAL
Intervention: Refraction intervention
Number of subjects: 3821
Study 10865321 — intervention group
Group type: EXPERIMENTAL
Intervention: Best-corrected acuity worse than 20/40
Number of subjects: 3821
Study 10865321 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual impairment among African Americans
Number of subjects: 3821
Study 10865321 — intervention group
Group type: EXPERIMENTAL
Intervention: Causes of impairment and blindness
Number of subjects: 3821
Study 9354111 — intervention group
Group type: EXPERIMENTAL
Intervention: Right nostril breathing
Number of subjects: 108
Study 9354111 — intervention group
Group type: EXPERIMENTAL
Intervention: Left nostril breathing
Number of subjects: 108
Study 9354111 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternate nostril breathing
Number of subjects: 108
Study 9354111 — intervention group
Group type: EXPERIMENTAL
Intervention: Breath awareness without manipulation of nostrils
Number of subjects: 108
Study 9354111 — intervention group
Group type: COMPARATOR
Intervention: Control group (age-matched, N = 27)
Number of subjects: 108
Study 7692110 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg finasteride
Number of subjects: 27
Study 7692110 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg finasteride
Number of subjects: 27
Study 7692110 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 3816290 — intervention group
Group type: EXPERIMENTAL
Intervention: Merieux rubella vaccine
Number of subjects: 100
Study 3816290 — intervention group
Group type: EXPERIMENTAL
Intervention: Wellcome RA27/3 rubella vaccine
Number of subjects: 100
Study 3816290 — intervention group
Group type: EXPERIMENTAL
Intervention: Low pre-vaccine titre subjects
Number of subjects: 100
Study 3816290 — intervention group
Group type: EXPERIMENTAL
Intervention: High pre-vaccine titre subjects
Number of subjects: 100
Study 3816290 — intervention group
Group type: COMPARATOR
Intervention: Both vaccines
Number of subjects: 100
Study 29808324 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBO), treated once daily at a pressure of 2.0 atm absolute with 100% oxygen.
Number of subjects: 73
Study 29808324 — intervention group
Group type: COMPARATOR
Intervention: No hyperbaric oxygen therapy (no-HBO), standard arm.
Number of subjects: 73
Study 26679552 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic resorbable pin fixation (URPF)
Number of subjects: 10
Study 26679552 — intervention group
Group type: COMPARATOR
Intervention: Hyaluronic acid (HA)
Number of subjects: 10
Study 24800227 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive video-assisted thyroidectomy (MIVAT)
Number of subjects: 0
Study 24800227 — intervention group
Group type: COMPARATOR
Intervention: Minimally invasive nonendoscopic thyroidectomy (MINET)
Number of subjects: 0
Study 22119930 — intervention group
Group type: EXPERIMENTAL
Intervention: G-CSF (5 μg/kg subcutaneously, 12 doses)
Number of subjects: 47
Study 20124207 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin (average daily dosage 385.7 mg/d)
Number of subjects: 302
Study 20124207 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 302
Study 20124207 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 302
Study 17593563 — intervention group
Group type: EXPERIMENTAL
Intervention: Violent video game play
Number of subjects: 0
Study 17593563 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 0
Study 16202888 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 mg/kg/d zoniporide
Number of subjects: 824
Study 16202888 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 824
Study 12134176 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiepileptic drugs (AEDs) treatment for 6 months in group A
Number of subjects: 81
Study 12134176 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiepileptic drugs (AEDs) treatment for 1 year in group B
Number of subjects: 81
Study 10201661 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine (n = 34)
Number of subjects: 73
Study 10201661 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine (n = 39)
Number of subjects: 73
Study 10201661 — intervention group
Group type: COMPARATOR
Intervention: Ropivacaine
Number of subjects: 73
Study 10201661 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine
Number of subjects: 73
Study 7539873 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy (cisplatin 20 mg/m2 day 1-5, bleomycin 10 mg/m2 continuous infusion from day 3-7, methotrexate 40 mg/m2 on day 15 and day 22, repeated on day 29 for two cycles)
Number of subjects: 54
Study 7539873 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (surgery + radiation)
Number of subjects: 54
Study 2178412 — intervention group
Group type: EXPERIMENTAL
Intervention: Digoxin
Number of subjects: 7
Study 2178412 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 7004254 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycopyrrolate
Number of subjects: 0
Study 7004254 — intervention group
Group type: COMPARATOR
Intervention: Atropine
Number of subjects: 0
Study 31063479 — intervention group
Group type: EXPERIMENTAL
Intervention: Spanish version of the Düsseldorfer Ortorexie Skala (DOS)
Number of subjects: 492
Study 31063479 — intervention group
Group type: EXPERIMENTAL
Intervention: Exploratory factor analysis
Number of subjects: 492
Study 31063479 — intervention group
Group type: EXPERIMENTAL
Intervention: Confirmatory factor analysis
Number of subjects: 492
Study 27033346 — intervention group
Group type: EXPERIMENTAL
Intervention: ToyBox-intervention (1-year intervention including physical activity sessions, classroom activities, environmental changes, and tools for parents)
Number of subjects: 1293
Study 27033346 — intervention group
Group type: EXPERIMENTAL
Intervention: ToyBox-intervention
Number of subjects: 1293
Study 25725181 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol‐atracurium
Number of subjects: 224
Study 25725181 — intervention group
Group type: COMPARATOR
Intervention: Thiopental‐atracurium
Number of subjects: 224
Study 23504678 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia (group 1)
Number of subjects: 110
Study 23504678 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anesthesia (group 2)
Number of subjects: 110
Study 20679501 — intervention group
Group type: EXPERIMENTAL
Intervention: Single 150 mg dose of caspofungin
Number of subjects: 36
Study 20679501 — intervention group
Group type: EXPERIMENTAL
Intervention: Single 210 mg dose of caspofungin
Number of subjects: 36
Study 20679501 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple 100 mg doses of caspofungin for 21 days
Number of subjects: 36
Study 19729951 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy (HRT) for 6 months
Number of subjects: 26
Study 17241413 — intervention group
Group type: EXPERIMENTAL
Intervention: BoNTA(2) (Dysport, Ipsen Ltd.) at dose ratios of 1:2.5, 1:3, or 1:4
Number of subjects: 20
Study 17241413 — intervention group
Group type: COMPARATOR
Intervention: BoNTA(1) (BOTOX, Allergan, Inc.)
Number of subjects: 20
Study 15078741 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimesulide, 100 mg orally twice daily
Number of subjects: 30
Study 15078741 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen, 400 mg orally three times daily
Number of subjects: 30
Study 15078741 — intervention group
Group type: COMPARATOR
Intervention: Control group (no NSAIDs)
Number of subjects: 30
Study 11192875 — intervention group
Group type: EXPERIMENTAL
Intervention: SOUNDTEC Direct Drive Hearing System (DDHS)
Number of subjects: 10
Study 9252814 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent impulse compression
Number of subjects: 60
Study 9252814 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous cryotherapy
Number of subjects: 60
Study 9252814 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (cool packs)
Number of subjects: 60
Study 8510986 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 30
Study 8510986 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 3604971 — intervention group
Group type: EXPERIMENTAL
Intervention: 1:1 mixture of xanthan and locust bean gum (X/LBG)
Number of subjects: 0
Study 3604971 — intervention group
Group type: COMPARATOR
Intervention: Guar gum, xanthan, locust-bean gum
Number of subjects: 0
Study 31648661 — intervention group
Group type: EXPERIMENTAL
Intervention: Consanguineous marriages
Number of subjects: 5255
Study 31648661 — intervention group
Group type: EXPERIMENTAL
Intervention: Arranged marriages
Number of subjects: 5255
Study 31648661 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental consanguinity in patients with β-thalassaemia
Number of subjects: 5255
Study 27575546 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg RAD1901 daily for 28 days
Number of subjects: 100
Study 27575546 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 27575546 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg RAD1901 daily for 28 days
Number of subjects: 100
Study 27575546 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg RAD1901 daily for 28 days
Number of subjects: 100
Study 27575546 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg RAD1901 daily for 28 days
Number of subjects: 100
Study 25769196 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral approach
Number of subjects: 216
Study 25769196 — intervention group
Group type: COMPARATOR
Intervention: Posterior approach
Number of subjects: 216
Study 24223362 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen plus honey
Number of subjects: 104
Study 24223362 — intervention group
Group type: COMPARATOR
Intervention: Acetaminophen plus placebo
Number of subjects: 104
Study 21297561 — intervention group
Group type: COMPARATOR
Intervention: Single-trial line drill test (SLDT)
Number of subjects: 24
Study 21297561 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-trial line drill test (SLDT) in basketball players (BP)
Number of subjects: 24
Study 19789532 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab with first-line chemotherapy
Number of subjects: 1914
Study 19789532 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 1914
Study 19789532 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1914
Study 16931172 — intervention group
Group type: EXPERIMENTAL
Intervention: Kcanrenoate (100 mg/day)
Number of subjects: 120
Study 16931172 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 15063399 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid fortification (1998)
Number of subjects: 18
Study 15063399 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivitamin supplementation for 10 weeks
Number of subjects: 18
Study 15063399 — intervention group
Group type: COMPARATOR
Intervention: Baseline measurements (1997)
Number of subjects: 18
Study 11560098 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 micrograms ethinyl estradiol plus 125 micrograms levonorgestrel
Number of subjects: 13
Study 11560098 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 micrograms ethinyl estradiol plus 150 micrograms desogestrel
Number of subjects: 13
Study 11560098 — intervention group
Group type: COMPARATOR
Intervention: Control cycle (early follicular phase)
Number of subjects: 13
Study 9624787 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol xinafoate 50 micrograms twice daily via the Diskus inhaler
Number of subjects: 263
Study 9624787 — intervention group
Group type: COMPARATOR
Intervention: Terbutaline sulphate 500 micrograms four times daily via the Turbuhaler inhaler
Number of subjects: 263
Study 9624787 — intervention group
Group type: EXPERIMENTAL
Intervention: Diskus inhaler
Number of subjects: 263
Study 9624787 — intervention group
Group type: COMPARATOR
Intervention: Turbuhaler inhaler
Number of subjects: 263
Study 7825420 — intervention group
Group type: EXPERIMENTAL
Intervention: Fotil (0.5% timolol and 2% pilocarpine)
Number of subjects: 89
Study 7825420 — intervention group
Group type: EXPERIMENTAL
Intervention: Timpilo (0.5% timolol and 2% pilocarpine)
Number of subjects: 89
Study 7825420 — intervention group
Group type: COMPARATOR
Intervention: Both Fotil and Timpilo
Number of subjects: 89
Study 7825420 — intervention group
Group type: EXPERIMENTAL
Intervention: Fotil
Number of subjects: 89
Study 7825420 — intervention group
Group type: EXPERIMENTAL
Intervention: Timpilo
Number of subjects: 89
Study 3135698 — intervention group
Group type: EXPERIMENTAL
Intervention: Vented group (4.5 mm lateral drill hole 4 cm distal the tip of the prosthesis)
Number of subjects: 26
Study 3135698 — intervention group
Group type: COMPARATOR
Intervention: Control group (no venting hole)
Number of subjects: 26
Study 31599479 — intervention group
Group type: EXPERIMENTAL
Intervention: AVB‐S6‐500 at a dose of 1 mg/kg
Number of subjects: 0
Study 31599479 — intervention group
Group type: EXPERIMENTAL
Intervention: AVB‐S6‐500 at a dose of 5 mg/kg
Number of subjects: 0
Study 31599479 — intervention group
Group type: EXPERIMENTAL
Intervention: AVB‐S6‐500 at a dose of 10 mg/kg
Number of subjects: 0
Study 30672256 — intervention group
Group type: EXPERIMENTAL
Intervention: shu-deep needling and bloodletting technique
Number of subjects: 70
Study 30672256 — intervention group
Group type: COMPARATOR
Intervention: regular needling technique (even-needling technique)
Number of subjects: 70
Study 30672256 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 70
Study 28780718 — intervention group
Group type: EXPERIMENTAL
Intervention: Biodentine®
Number of subjects: 51
Study 28780718 — intervention group
Group type: EXPERIMENTAL
Intervention: Mineral Trioxide Aggregate
Number of subjects: 51
Study 28780718 — intervention group
Group type: COMPARATOR
Intervention: Formocresol (Control)
Number of subjects: 51
Study 26887115 — intervention group
Group type: EXPERIMENTAL
Intervention: Yagel-Detox
Number of subjects: 150
Study 26887115 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study 24600731 — intervention group
Group type: EXPERIMENTAL
Intervention: Devil's claw root
Number of subjects: 20
Study 24600731 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 21922934 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended essential oil (lavender and bergamot) applied topically to the skin of the abdomen
Number of subjects: 40
Study 21922934 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended essential oil (lavender and bergamot)
Number of subjects: 40
Study 21922934 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 40
Study 19214928 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroids given acutely for Bell's palsy
Number of subjects: 0
Study 19214928 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiviral therapy for Ramsay Hunt syndrome
Number of subjects: 0
Study 19214928 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiviral therapy for severe cases of Bell's palsy
Number of subjects: 0
Study 19214928 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics for Lyme facial neuropathy
Number of subjects: 0
Study 16749407 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg barnidipine
Number of subjects: 85
Study 16749407 — intervention group
Group type: COMPARATOR
Intervention: 10 mg benazepril
Number of subjects: 85
Study 16749407 — intervention group
Group type: COMPARATOR
Intervention: Control (benazepril)
Number of subjects: 85
Study 14715881 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human IGF‐I
Number of subjects: 0
Study 14715881 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human GH
Number of subjects: 0
Study 14715881 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 11758305 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT)
Number of subjects: 60
Study 11758305 — intervention group
Group type: COMPARATOR
Intervention: Surgical treatment
Number of subjects: 60
Study 9272538 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardioversion with subsequent antiarrhythmic drug therapy
Number of subjects: 0
Study 9272538 — intervention group
Group type: COMPARATOR
Intervention: Control of the ventricular rate during persistent atrial fibrillation
Number of subjects: 0
Study 8204701 — intervention group
Group type: EXPERIMENTAL
Intervention: Regimen GL (glucose-lipid-based TPN)
Number of subjects: 17
Study 8204701 — intervention group
Group type: COMPARATOR
Intervention: Regimen G (glucose-based TPN)
Number of subjects: 17
Study 8204701 — intervention group
Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 17
Study 3335727 — intervention group
Group type: EXPERIMENTAL
Intervention: 45 minutes of exercise
Number of subjects: 15
Study 3335727 — intervention group
Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 15
Study 3335727 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 15
Study 3335727 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 15
Study 31668693 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticholinergic drug scale (ADS) score assessment
Number of subjects: 651
Study 31668693 — intervention group
Group type: EXPERIMENTAL
Intervention: Age (per year)
Number of subjects: 651
Study 31668693 — intervention group
Group type: EXPERIMENTAL
Intervention: ASA state
Number of subjects: 651
Study 31668693 — intervention group
Group type: EXPERIMENTAL
Intervention: ICU stay (yes vs. no)
Number of subjects: 651
Study 30204916 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard ECD program with additional activities to improve nutritious food production and behavior change communication
Number of subjects: 1552
Study 30204916 — intervention group
Group type: COMPARATOR
Intervention: Save the Children's ECD program
Number of subjects: 1552
Study 28805611 — intervention group
Group type: EXPERIMENTAL
Intervention: Short I-D interval (1 mg/kg propofol and 1 μg/kg remifentanil; maintained by continuous infusion of 3 mg/kg/h propofol and 7 μg/kg/h remifentanil)
Number of subjects: 40
Study 28805611 — intervention group
Group type: EXPERIMENTAL
Intervention: Long I-D interval (1 mg/kg propofol and 1 μg/kg remifentanil; maintained by continuous infusion of 3 mg/kg/h propofol and 7 μg/kg/h remifentanil)
Number of subjects: 40
Study 28805611 — intervention group
Group type: COMPARATOR
Intervention: Both groups (short and long I-D intervals)
Number of subjects: 40
Study 25664962 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Pycnogenol®, roburins, L‐arginine, L‐citrulline
Number of subjects: 50
Study 25664962 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50